Deleted Tweets From Scott Gottlieb, R-D.C.

FDA’s Center for Veterinary Medicine protects both human and animal health. To learn more about animal health topics from pet food to heartworm visit https://t.co/nbmju2DUSK. Info on recalls and withdrawals of animal & veterinary products is found here https://t.co/zIUd3w5MlA https://t.co/VAQyeN7rDU

FDA provides information regarding the measures we take when a food product is mislabeled, presents a health risk because of contamination, or has caused an outbreak of illness. For a list of food and dietary supplement recalls, visit https://t.co/OM1YT5FZuR https://t.co/LJULIrBsB3

While FDA does not approve cosmetic products before they are marketed, we can act against a cosmetic on the market if we have reliable info showing that a product is adulterated or misbranded. Learn more & get info on recalls & other enforcement actions https://t.co/02fMyXgrEn https://t.co/I6QDKjYYNV

Tobacco use remains a major problem in the U.S. – one that FDA is working hard to address. Among other efforts, we are investing in several public campaigns to help educate about the dangers of tobacco products. Health info re. tobacco can be found here https://t.co/d9B6P143Ev https://t.co/Dar1S1yMDH

Want to learn more about food safety and nutrition? Visit our Education Resource Library, a catalog of printable educational materials and videos intended for consumers, educators, dietitians and health professionals https://t.co/tzLCaOl2T0 https://t.co/wQp7K2aR4e

Your voice as a patient or family member is very important to us. We are undertaking several initiatives to better understand patient needs and incorporate their voice into drug and device development https://t.co/6bHDj0OY5D https://t.co/AwNWNY1Isp

We will hold a public workshop re:our draft patient-focused drug development guidance to discuss our approach to identifying what’s important to patients & caregivers re. the burden of disease & better understand what clinical outcomes are relevant to them https://t.co/FPwyGBkpT0

Other initiatives for patients to engage with FDA include Listening Sessions in Rare Diseases through an MOU with NORD, the Patient Engagement Collaborative, the Patient Engagement Advisory Committee and the Patient Representative Program https://t.co/UANbkSp5c9

RT @SGottliebFDA: One of the ways #FDA achieves its mission of protecting and promoting public health is by providing accurate, scien… https://t.co/KMpskSMsg3

#FDA is committed to increasing patient involvement in the regulatory work we do, building on both the Cures Act and #FDARA. Our Patient Affairs Staff works with patients and supporting cross-cutting patient engagement activities across the FDA https://t.co/a5LDmhO84I

RT @JohnCendpts: FDA drafts guidance on seamless clinical trials for cancer drug developers @ZacharyBrennan https://t.co/r0QKO96TKY

RT @FDAPatientinfo: Be sure to check out this week's #SUNDAYTWEETORIAL from Dr. @SGottliebFDA which features #FDA resources for patients an… QT @SGottliebFDA: One of the ways #FDA achieves its mission of protecting and promoting public health is by providing accurate, scien… https://t.co/KMpskSMsg3)

RT @FDAOncology: #FDAOncology has posted the Pediatric Molecular Targets List to provide guidance to industry in planning for initia… https://t.co/We9W8EsACj

2/3 Providing manufacturers additional information about #FDA’s science-based application review decisions can help them better understand options for addressing the agency’s concerns and help make sure new tobacco products meet our regulatory standards: https://t.co/oDFaYacBar

RT @US_FDA: On July 12, FDA announced an investigation into a potential link between dogs’ diets and canine heart disease. Here… https://t.co/J3XsLjz7HV

THREAD: 1/3 #FDA is taking steps to improve efficiency and transparency of the tobacco product application review process as part of commitments made when we unveiled our comprehensive framework last summer. We will announce addt’l improvements this fall: https://t.co/oDFaYacBar

RT @NCIDirector: Quality discussion about how @SGottliebFDA ’s diagnosis of stage 1 Hodgkin’s Lymphoma in 2006 impacted his outlook… https://t.co/7YJ9S6Pp88

#FDA recently issued a Warning Letter to a website selling PoppySeed Wash, which illegally claims to treat, prevent diseases. PoppySeed Wash is not an FDA approved drug. Consumers should speak with a health care provider on suitable pain management options https://t.co/FMtDULbMXl

3/3 We’re committed to the effective and appropriate regulatory oversight of tobacco products as part of our comprehensive efforts to protect kids and significantly reduce tobacco-related disease and death: https://t.co/oDFaYacBar

#FDA recognizes the need for alternative therapies for the treatment of pain, however poppy seeds have not been proven safe or effective for medical use. All patients in pain should benefit from skillful and appropriate care by seeking help from their HCP. https://t.co/8NKeraQdBR

FDA’s Center for Veterinary Medicine protects both human and animal health. To learn more about animal health topics from pet food to heartworm visit https://t.co/nbmju2DUSK. Info on recalls and withdrawals of animal & veterinary products is found here https://t.co/zIUd3w5MlA https://t.co/VAQyeN7rDU

FDA provides information regarding the measures we take when a food product is mislabeled, presents a health risk because of contamination, or has caused an outbreak of illness. For a list of food and dietary supplement recalls, visit https://t.co/OM1YT5FZuR https://t.co/LJULIrBsB3

While FDA does not approve cosmetic products before they are marketed, we can act against a cosmetic on the market if we have reliable info showing that a product is adulterated or misbranded. Learn more & get info on recalls & other enforcement actions https://t.co/02fMyXgrEn https://t.co/I6QDKjYYNV

Tobacco use remains a major problem in the U.S. – one that FDA is working hard to address. Among other efforts, we are investing in several public campaigns to help educate about the dangers of tobacco products. Health info re. tobacco can be found here https://t.co/d9B6P143Ev https://t.co/Dar1S1yMDH

Want to learn more about food safety and nutrition? Visit our Education Resource Library, a catalog of printable educational materials and videos intended for consumers, educators, dietitians and health professionals https://t.co/tzLCaOl2T0 https://t.co/wQp7K2aR4e

Your voice as a patient or family member is very important to us. We are undertaking several initiatives to better understand patient needs and incorporate their voice into drug and device development https://t.co/6bHDj0OY5D https://t.co/AwNWNY1Isp

We will hold a public workshop re:our draft patient-focused drug development guidance to discuss our approach to identifying what’s important to patients & caregivers re. the burden of disease & better understand what clinical outcomes are relevant to them https://t.co/FPwyGBkpT0

Other initiatives for patients to engage with FDA include Listening Sessions in Rare Diseases through an MOU with NORD, the Patient Engagement Collaborative, the Patient Engagement Advisory Committee and the Patient Representative Program https://t.co/UANbkSp5c9

RT @SGottliebFDA: One of the ways #FDA achieves its mission of protecting and promoting public health is by providing accurate, scien… https://t.co/KMpskSMsg3

#FDA is committed to increasing patient involvement in the regulatory work we do, building on both the Cures Act and #FDARA. Our Patient Affairs Staff works with patients and supporting cross-cutting patient engagement activities across the FDA https://t.co/a5LDmhO84I

RT @JohnCendpts: FDA drafts guidance on seamless clinical trials for cancer drug developers @ZacharyBrennan https://t.co/r0QKO96TKY

RT @FDAPatientinfo: Be sure to check out this week's #SUNDAYTWEETORIAL from Dr. @SGottliebFDA which features #FDA resources for patients an… QT @SGottliebFDA: One of the ways #FDA achieves its mission of protecting and promoting public health is by providing accurate, scien… https://t.co/KMpskSMsg3)

RT @FDAOncology: #FDAOncology has posted the Pediatric Molecular Targets List to provide guidance to industry in planning for initia… https://t.co/We9W8EsACj

2/3 Providing manufacturers additional information about #FDA’s science-based application review decisions can help them better understand options for addressing the agency’s concerns and help make sure new tobacco products meet our regulatory standards: https://t.co/oDFaYacBar

RT @US_FDA: On July 12, FDA announced an investigation into a potential link between dogs’ diets and canine heart disease. Here… https://t.co/J3XsLjz7HV

THREAD: 1/3 #FDA is taking steps to improve efficiency and transparency of the tobacco product application review process as part of commitments made when we unveiled our comprehensive framework last summer. We will announce addt’l improvements this fall: https://t.co/oDFaYacBar

RT @NCIDirector: Quality discussion about how @SGottliebFDA ’s diagnosis of stage 1 Hodgkin’s Lymphoma in 2006 impacted his outlook… https://t.co/7YJ9S6Pp88

#FDA recently issued a Warning Letter to a website selling PoppySeed Wash, which illegally claims to treat, prevent diseases. PoppySeed Wash is not an FDA approved drug. Consumers should speak with a health care provider on suitable pain management options https://t.co/FMtDULbMXl

3/3 We’re committed to the effective and appropriate regulatory oversight of tobacco products as part of our comprehensive efforts to protect kids and significantly reduce tobacco-related disease and death: https://t.co/oDFaYacBar

#FDA recognizes the need for alternative therapies for the treatment of pain, however poppy seeds have not been proven safe or effective for medical use. All patients in pain should benefit from skillful and appropriate care by seeking help from their HCP. https://t.co/8NKeraQdBR